Compare metabolites in 2 of these studies:
Study A:   Study B:  

List of Studies ( Metabolite:Lipoxin A5)

Study_idAnalysis_idStudy_titleSourceSpeciesDiseaseInstituteAnalysis Type
ST003931 AN006454 Acylated putrescine therapeutic discovery for Inflammatory Bowel Diseases: HILIC-neg, C8-pos and C18-neg profiling of mouse fecal samples Feces Mouse Inflammatory bowel disease Broad Institute of MIT and Harvard LC-MS
ST003768 AN006186 The Chromosome-Scale Assembly and Multi-Omics Analysis Reveal Adaptive Evolution and Nitrogen Utilization Mechanisms in Edible Grass Leaf Grass Hunan Agricultural University LC-MS
ST003768 AN006186 The Chromosome-Scale Assembly and Multi-Omics Analysis Reveal Adaptive Evolution and Nitrogen Utilization Mechanisms in Edible Grass Roots Grass Hunan Agricultural University LC-MS
ST003378 AN005531 Effects of Aldehydes on lipid metabolism in mice Liver Mouse Liver disease Feinstein Institutes for Medical Research LC-MS
ST003378 AN005531 Effects of Aldehydes on lipid metabolism in mice Liver Mouse Obesity Feinstein Institutes for Medical Research LC-MS
ST002823 AN004603 Smoking Induced Gut Microbial Dysbiosis Mediates Cancer Progression Through Adaptive Immune System Modulation Feces Mouse Cancer University of Alabama, Birmingham LC-MS
ST002455 AN004005 Organism-Wide Analysis of Sepsis Reveals Mechanisms of Systemic Inflammation Blood Mouse Sepsis University of Chicago LC-MS
ST002354 AN003843 Combination of TP-252 and Naproxen elicit tumor protective Eicosanoid changes. Blood Rat Cancer UConn Health LC-MS
ST002354 AN003843 Combination of TP-252 and Naproxen elicit tumor protective Eicosanoid changes. Colon Rat Cancer UConn Health LC-MS
ST002354 AN003845 Combination of TP-252 and Naproxen elicit tumor protective Eicosanoid changes. Blood Rat Cancer UConn Health LC-MS
ST002354 AN003845 Combination of TP-252 and Naproxen elicit tumor protective Eicosanoid changes. Colon Rat Cancer UConn Health LC-MS
  logo